Status:
COMPLETED
Cognitive Impact in Patients With COVID-19 Infection
Lead Sponsor:
Assiut University
Conditions:
Cognitive Impairment
COVID-19 Respiratory Infection
Eligibility:
All Genders
18+ years
Brief Summary
SARS-COV-2 (severe acute respiratory syndrome- corona virus - 2) infection reframed medical knowledge in many aspects, yet there is still a lot to be discovered. Coronavirus disease 19 (COVID-19) can ...
Detailed Description
COVID-19 results in a variety of symptoms with multi-organ affection, including fever, cough; grave respiratory symptoms, gastrointestinal manifestations and fatigue. As more is learned, neurological ...
Eligibility Criteria
Inclusion
- COVID-19 patients diagnosed using Real Time-Polymerase Chain Reaction to confirm the diagnosis
Exclusion
- neurological disorders, psychological disorders, dementia, Alzheimer's disease, end-organ failure conditions
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05293561
Start Date
June 1 2021
End Date
December 1 2022
Last Update
January 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University
Asyut, Egypt, 711111